J&j

J&J gets plaintiff backing for $6.5 bn to resolve lawsuits over baby powder

Separately, the company said in May it has resolved 95% of claims its baby powder was tainted with asbestos and caused mesothelioma, a type of cancer that forms in tissues around the heart and lungs

Sitharaman to introduce J&K Appropriation Bill in the Lok Sabha: What is it

This Jammu and Kashmir Appropriation Bill, 2024 seeks to authorise the withdrawal of sums from the Consolidated Fund of the Union Territory for FY25

J&J talc users want cancer checks for women even if it cost billions

The suit is the latest salvo in the ongoing legal battle between J&J and former talc users, who allege the world's largest maker of health-care products hid the cancer risks of its iconic baby powder

J&J weighs third bankruptcy try to settle baby powder cancer case

Attorneys for some plaintiffs opposed the idea of a return to bankruptcy court

New Jersey court tosses $223.8 mn verdict against J&J in talc cancer case

J&J is separately suing one of those experts, Jacqueline Moline, over a study she co-authored in 2019. That study was not at issue in Tuesday's decision

J&J can't use bankruptcy to settle 100,000 baby powder cancer claims: Judge

J&J shares dropped as much as 3.4% in post-market trading following the ruling. The company vowed to appeal Judge Kaplan's ruling

J&J's proposed $8.9 bn talc lawsuits settlement faces US bankruptcy test

US bankruptcy law typically shields debtors from lawsuits while they reorganize in bankruptcy

J&J's proposed talc settlement would pay $400 million to US state AGs

J&J subsidiary LTL Management filed a bankruptcy plan in New Jersey late on Monday that details how the company intends to pay different types of cancer victims in a bankruptcy settlement

J&J accused by US of misusing bankruptcy to end talc cancer suits

J&J has an $8.9 billion settlement agreement with the "vast majority" of the law firms representing talc claimants, said the company's head of litigation

J&J proposes paying $8.9 bn to settle baby talcum powder lawsuits

Johnson & Johnson is earmarking nearly USD 9 billion to cover allegations that its baby power containing talc caused cancer, more than quadrupling the amount that the company had previously set aside to pay for its potential liability. Under a proposal announced Tuesday, a J&J subsidiary will re-file for Chapter 11 bankruptcy protection and seek court approval for a plan that would result in one of the largest product-liability settlements in U.S. history. The USD 8.9 billion that J&J would transfer to the subsidiary, LTL Management, would be payable over the next 25 years. The amount is up from the USD 2 billion that the New Brunswick, New Jersey, company set aside in October 2021. The revised amount is being backed by more than 60,000 parties that have filed lawsuits alleging harm from J&J talcum powder, according to the company. J&J isn't admitting any wrongdoing as part of the proposed settlement, a point that company executive emphasised in a Tuesday statement

J&J forecasts strong profit, beats Wall Street estimates on pharma boost

Shares of the drugmaker were up nearly 1% at $170.28 in trading before the bell

Maharashtra FDA cancels manufacturing licence of J&J baby powder

The state government body also said that the use of the product may affect the health of the skin of newborn babies

Explained: What is the controversy around J&J's talc-based baby powder?

Johnson and Johnson (J&J) has been facing several thousand lawsuits from women who claim that they developed ovarian cancer after using the product

Johnson & Johnson to stop selling personal care products in Russia

(Reuters) -Johnson & Johnson said on Tuesday it would halt sale of personal care products in Russia, joining other companies that have limited their business in the country in response to its invasion of Ukraine.

Expert panel allows adolescent trials of J&J vaccine with riders

SEC asks J&J to monitor adverse events closely for next three months

J&J seeks FDA's approval for Covid-19 vaccine booster shot in adults

If authorized, J&J's booster could give millions more Americans additional protection against the coronavirus

India to make available 8 mn doses of J&J Covid vax: PM Modi at Quad Summit

India will make available 8 million doses of the Johnson and Johnson vaccine by the end of October under the Quad vaccine partnership, Foreign Secretary Harsh Vardhan Shringla on Friday informed.

Johnson & Johnson says Covid-19 booster shot is 94% effective

J&J said a booster given two months after the first dose increased antibody levels four to six-fold

J&J says coronavirus vaccine booster shot triggered an antibody surge

ignificant increases in antibody responses were seen in subjects ages 18 to 55 years old, and among those 65 or older who were given a lower dose of the booster.

Joaquin Duato set to replace Alex Gorsky as Johnson & Johnson's CEO

Duato, 59, currently serves as vice chairman of J&J's executive committee